Inducing Targeted Protein Degradation (eBook, PDF)
From Chemical Biology to Drug Discovery and Clinical Applications
Redaktion: Cromm, Philipp
133,99 €
133,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
133,99 €
Als Download kaufen
133,99 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
133,99 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
0 °P sammeln
Inducing Targeted Protein Degradation (eBook, PDF)
From Chemical Biology to Drug Discovery and Clinical Applications
Redaktion: Cromm, Philipp
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
The guide to induced protein degradation for drug developers in academia and industry surveys established and novel approaches in the field, with an eye on expanding the range of druggable targets.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 50.99MB
Andere Kunden interessierten sich auch für
- Inducing Targeted Protein Degradation (eBook, ePUB)133,99 €
- Successful Drug Discovery, Volume 5 (eBook, PDF)133,99 €
- Drug Development for Malaria (eBook, PDF)133,99 €
- New Drug Development for Known and Emerging Viruses (eBook, PDF)171,99 €
- Open Access Databases and Datasets for Drug Discovery (eBook, PDF)142,99 €
- Drug and Therapy Development for Triple Negative Breast Cancer (eBook, PDF)124,99 €
- RNA as a Drug Target (eBook, PDF)142,99 €
-
-
-
The guide to induced protein degradation for drug developers in academia and industry surveys established and novel approaches in the field, with an eye on expanding the range of druggable targets.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in D ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley-VCH
- Erscheinungstermin: 9. November 2022
- Englisch
- ISBN-13: 9783527350179
- Artikelnr.: 66452089
- Verlag: Wiley-VCH
- Erscheinungstermin: 9. November 2022
- Englisch
- ISBN-13: 9783527350179
- Artikelnr.: 66452089
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Philipp M. Cromm studied Chemistry at the Technical University Munich where he worked in the group of Horst Kessler. For his master's thesis he spent time with David J. Craik at the Institute for Molecular Bioscience and received his PhD under guidance of Herbert Waldmann at the Max-Planck-Institute for Molecular Physiology. Thereafter, he carried out postdoctoral studies in the group of Craig Crews at Yale University working on targeted protein degradation. In 2018 Philipp joined Bayer AG as a Medicinal Chemist.
Targeted Protein Degradation - The Story So Far
Cellular Principles of Targeted Protein Degradation
E3 Ubiquitin Ligases as Molecular Machines and Platforms for Drug Development
A Structural and Biophysical Perspective of Degrader Activity through Ternary Complex Formation
Computational Modeling of PROTAC Ternary Complexes and Linker Design
Molecular Glue Degraders: From Serendipity to Hunting and Design
Targeted Protein Degradation as a Therapeutic Strategy in Neurodegenerative Diseases
Insights and Future Perspectives of Covalent Protein Degraders
Extending the Degradation Toolkit - mRNA targeting as Alternative Means to Affect Protein Levels
The Future of Heterobifunctional Compounds: PROTACs and Beyond
Destruction with a Purpose: Targeted Protein Degradation in Drug Discovery
Taming the Beast: How to Optimize DMPK-PD Properties of Oral Degraders
PROTAC® Protein Degraders: Bridging the Divide from Chemical Biology Tools to Clinical Candidates
Cellular Principles of Targeted Protein Degradation
E3 Ubiquitin Ligases as Molecular Machines and Platforms for Drug Development
A Structural and Biophysical Perspective of Degrader Activity through Ternary Complex Formation
Computational Modeling of PROTAC Ternary Complexes and Linker Design
Molecular Glue Degraders: From Serendipity to Hunting and Design
Targeted Protein Degradation as a Therapeutic Strategy in Neurodegenerative Diseases
Insights and Future Perspectives of Covalent Protein Degraders
Extending the Degradation Toolkit - mRNA targeting as Alternative Means to Affect Protein Levels
The Future of Heterobifunctional Compounds: PROTACs and Beyond
Destruction with a Purpose: Targeted Protein Degradation in Drug Discovery
Taming the Beast: How to Optimize DMPK-PD Properties of Oral Degraders
PROTAC® Protein Degraders: Bridging the Divide from Chemical Biology Tools to Clinical Candidates
Targeted Protein Degradation - The Story So Far
Cellular Principles of Targeted Protein Degradation
E3 Ubiquitin Ligases as Molecular Machines and Platforms for Drug Development
A Structural and Biophysical Perspective of Degrader Activity through Ternary Complex Formation
Computational Modeling of PROTAC Ternary Complexes and Linker Design
Molecular Glue Degraders: From Serendipity to Hunting and Design
Targeted Protein Degradation as a Therapeutic Strategy in Neurodegenerative Diseases
Insights and Future Perspectives of Covalent Protein Degraders
Extending the Degradation Toolkit - mRNA targeting as Alternative Means to Affect Protein Levels
The Future of Heterobifunctional Compounds: PROTACs and Beyond
Destruction with a Purpose: Targeted Protein Degradation in Drug Discovery
Taming the Beast: How to Optimize DMPK-PD Properties of Oral Degraders
PROTAC® Protein Degraders: Bridging the Divide from Chemical Biology Tools to Clinical Candidates
Cellular Principles of Targeted Protein Degradation
E3 Ubiquitin Ligases as Molecular Machines and Platforms for Drug Development
A Structural and Biophysical Perspective of Degrader Activity through Ternary Complex Formation
Computational Modeling of PROTAC Ternary Complexes and Linker Design
Molecular Glue Degraders: From Serendipity to Hunting and Design
Targeted Protein Degradation as a Therapeutic Strategy in Neurodegenerative Diseases
Insights and Future Perspectives of Covalent Protein Degraders
Extending the Degradation Toolkit - mRNA targeting as Alternative Means to Affect Protein Levels
The Future of Heterobifunctional Compounds: PROTACs and Beyond
Destruction with a Purpose: Targeted Protein Degradation in Drug Discovery
Taming the Beast: How to Optimize DMPK-PD Properties of Oral Degraders
PROTAC® Protein Degraders: Bridging the Divide from Chemical Biology Tools to Clinical Candidates